Latest From Biotech Now

National Patient Advocate Foundation: Cancer Patients are Being Left Behind

20070112

Roll Call published a commentary today by Nancy Davenport-Ennis of the National Patient Advocate Foundation on the effects of the sequester on cancer care. The op ed states that these ‘cuts are shown to directly impact patients through higher copayments, longer travel times and increased travel expenses, visits to multiple providers and locations for care and services, and delays seeking treatment even as cancer progresses.’  Despite these facts, some have called for even deeper cuts Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

CHI Program to Offer Tips for Acquiring Pipeline Funding

AB23475

Biomedical innovations rely largely on scientific breakthroughs, which in turn happen through well-structured research programs. CHI’s Pipeline for Life  will focus on what characterizes successful basic research models in the 21st century, during a time when researchers are experiencing declining governmental funding for science research. Collaboration between industry and academic partners will be necessary to keep the biomedical ecosystem healthy, and the industry’s pipeline full of innovation. This half-day program will explore the strategies and Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

Moving Inside the Beltway: Brief Health Roundup

Moving Inside the Beltway: Brief Health Roundup

We are working to move the following legislation forward: Immigration: S. 744, The Border Security, Economic Opportunity, and Immigration Modernization Act, includes provisions that would ensure employers with greater access to U.S.-trained immigrant scientists and engineers, and we are working to ensure that remains the case. As drafted, S. 744 would raise the cap on H-1B visas from 65,000 to 110,000, with an option to elevate the cap up to 180,000 based on market demand Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

SBIR Reauthorization Moves Forward

SBIR Reauthorization Moves Forward

NIH has reissued its Small Business Innovation Research (SBIR) Omnibus Grant Solicitation announcement, which states that small businesses that are majority-owned by multiple venture capital operating companies are eligible to apply for (1) these SBIR grants and (2) any other NIH SBIR funding opportunities announced after January 28, 2013.  The NIH grant solicitation announcement can be found here. With this re-issuance, small businesses that are majority-owned by multiple venture capital operating companies (VCOCs), hedge funds Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,

IP in Latin America: Growing Recognition of the Importance of IP to Innovation

Photo by Márcio Cabral de Moura

The Inter-American Dialogue’s daily Latin America Advisor recently asked the question “How seriously do Latin American countries protect IP rights?”  The editors asked various stakeholders about the U.S. Trade Representative’s Special 301 Report and its evaluation of Latin America’s protection of IP rights.  BIO’s Director for International Affairs, Meredith Fensom, commented on the growth of the innovative biotechnology sectors in Latin America and the critical role intellectual property plays.  “The presence of more than 60 Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,